Use of PP-1 inhibitors to prevent missplicing events

摘要

The present invention relates to methods and compositions for regulating splicings in mammalian cells. More particularly, the invention relates to the use of PP1 inhibitors to prevent abnormal splicings in various pathological situations. The invention may be used to prevent or treat various diseases, including degenerative diseases and cancers.